50 Minute Video | Jamilaah Cary, Bayer
Physicians and healthcare professionals often partner with medical device and pharmaceutical manufacturers for a variety of activities including clinical trials, educational research grants, and investigator initiated studies. These relationships have long benefited both parties; however, the financial interest invested by industry organizations has led governing bodies around the world to raise concern about the influences this has in the decision making process. As a result, many countries are working to implement a variety of transparency related initiatives and requirements, with the US spearheading the push in the passing of the Physician Payment Sunshine Act in 2013. While legal and compliance executives understand the policy and requirements of the Sunshine Act, many field-based teams remain unsure of the specific provisions and how it may affect them. With the first reporting deadline has come and gone, compliance trainers must ensure all field representatives are knowledgeable on recognizing when data collection is required, and knowing how and where to report the required information.
- CIA compliance training tactics, codes of conduct and tools for field representatives
- Outlining Sunshine specific training provisions and methods for compliance
- Method for educating teams on key risk areas
o Off-label promotion
- Reviewing recent enforcement trends and notable settlements
Participants that will find this webinar most beneficial will be those involved in medical device companies. Job titles of attendees that will be most applicable for this session will be:
- Training & Learning Management
- Sales Training
This webinar has been pre-approved by the Regulatory Affairs Professionals Society (RAPS) as eligible for up to 1.5 credits towards a participant’s RAC recertification upon full completion.
Purchase Video Recording
Jamillaah Cary currently serves as the Manager of Compliance Training with Bayer Corporation, where she’s responsible for directing a three-person professional staff and one direct full-time contractor with core responsibility to develop and manage the Bayer Healthcare-wide (12,000+ employees, temporary employees, consultants, contractors and agents) compliance training programs and initiatives, both required by the Corporate Integrity Agreement (CIA) and adhoc training, as well as monitor and evaluate training effectiveness based on identified risk areas.